Victor Forge
Myosin Heavy Chain (MyHC) is a protein that is considered the best marker for fibre typing in mammalian muscles. MyHC is encoded by the MYH gene and is expressed in different isoforms, including embryonic and neonatal (or perinatal) myosins. MyHC plays a crucial role in skeletal muscle differentiation during mammalian development, with mutations in the MYH3 gene leading to congenital contracture syndromes. In adult bovine skeletal muscle, four isoforms of MyHC are expressed, while three isoforms are functionally expressed in adult equine skeletal muscles. The relative content of these isoforms can change in response to exercise training. MyHC is also associated with cardiac health, with mutations in MYH6 linked to atrial septal defects and hypertrophic cardiomyopathy.
| Characteristics | Values |
|---|---|
| Definition | Myosin Heavy Chain (MyHC) is a protein that in humans is encoded by the MYH6 gene. |
| Types | MyHC has three isoforms (types 1, 2A, and 2X) in adult equine skeletal muscles. |
| Function | MyHC is a marker for fibre typing in mammalian muscles. It is also involved in muscle development and regeneration. |
| Expression | MyHC is widely expressed in body muscles and specialized skeletal muscles. |
| Regulation | MyHC gene regulation is complex and involves bidirectional intergenic promoters coordinating the expression of different isoforms. |
| Mutations | Mutations in MyHC genes can lead to various congenital contracture syndromes, distal arthrogryposis syndromes, and cardiac malformations. |
| Age-Related Changes | The expression of certain MyHC isoforms decreases with increasing age. |
| Training Adaptability | Equine muscle fibres exhibit a transformation in fibre type composition in response to exercise training. |
| Meat Quality | The expression of MyHC genes is associated with intramuscular fat content and meat tenderness in Simmental hybrid cattle. |
Explore related products
What You'll Learn
Myosin Heavy Chain (MyHC) is a marker for fibre typing in mammalian muscles
Myosin Heavy Chain (MyHC) is a contractile protein that is expressed during muscle development in mammals. It is the most abundant protein expressed in skeletal muscle, comprising about 35% of the protein pool. MyHC is considered the best marker for fibre typing in mammalian muscles.
Skeletal muscles consist of different fibre types that can be identified by immunohistochemistry using antibodies that recognize distinct myosin isoforms. Immunofluorescence analysis is a sensitive method that allows for the simultaneous evaluation of multiple MHC isoforms on a large number of fibres on a single cross-section, offering a more precise means of identifying fibre types.
In adult bovine skeletal muscle, four isoforms of the Myosin Heavy Chain (MyHC) gene have been identified: MyHC-I, MyHC-IIa, MyHC-IIb, and MyHC-IIx. These isoforms are translated into different structural protein myofibrils, which then form different types of muscle fibres. The expression levels of these isoforms vary with age, and they have been found to be negatively related to intramuscular fat content and meat shearing force.
MyHC also plays a crucial role in embryonic and fetal muscle development. Mutations in the MYH3 gene, which encodes MyHC-emb, can lead to congenital contracture syndromes such as Freeman-Sheldon and Sheldon-Hall. MyHC-emb performs both cell-autonomous and non-cell-autonomous functions during myogenesis, regulating muscle fibre size, number, and type.
In summary, Myosin Heavy Chain (MyHC) is a vital protein for muscle development and function in mammals. It serves as an excellent marker for fibre typing in mammalian muscles, allowing for the identification of different fibre types and their functional properties.
Deltoid Muscle: Understanding Its Function and Anatomy
You may want to see also
Explore related products
MyHC is a contractile protein expressed during muscle development
Myosin heavy chain (MyHC) is a contractile protein expressed during muscle development. It is considered the best marker for fibre typing in mammalian muscles. MyHC is coded by the myosin heavy chain 3 (MYH3) gene. It is expressed during the embryonic and fetal stages of muscle development, and mutations in the MYH3 gene coding for the MyHC-emb protein can cause congenital contracture syndromes.
MyHC-emb is a crucial regulator of mammalian myogenesis, which is the process of muscle development. It is expressed in myofibers and regulates muscle fibre size, number, and type. The loss of MyHC-emb function can lead to neonatal and postnatal alterations in muscle fibre characteristics, including fibre number, size, and type. These alterations can lead to conditions such as scoliosis and contracture syndromes.
During muscle development, unique myosin isoforms are expressed, including embryonic and neonatal myosin heavy chains. These isoforms are transiently expressed during embryonic and fetal development and disappear shortly after birth. However, they persist throughout adulthood in specialized muscles, such as the extraocular and jaw-closing muscles. The expression of these developmental myosins is correlated with specific developmental time points and myogenic phases.
The contractile velocity of muscles is directly correlated with their myosin ATPase activity and can be classified as fast or slow. MyHC isoforms play a crucial role in determining the contractile and non-contractile features of muscle fibres. The relative proportions of these fibre types change in response to exercise training. For example, the MyHC-2X transcript is rapidly down-regulated in horse muscle within 12-24 hours of exercise training.
In summary, MyHC is a contractile protein that plays a crucial role in muscle development and function. Its expression is dynamic and varies during different stages of development, with mutations leading to various congenital syndromes.
Slender Muscle Anatomy: Understanding the Term 'Gracile
You may want to see also
Explore related products
MyHC gene regulation is complex due to bidirectional promoters
Myosin heavy chain (MyHC) is considered the best marker for fibre typing in mammalian muscles. MyHC is a skeletal muscle-specific contractile protein expressed during muscle development. Mutations in the MYH3 gene, which encodes MyHC, lead to congenital contracture syndromes.
Gene regulation in mammals begins with transcription, which initiates at a gene's promoter. A gene's promoter is defined as the region upstream and encompassing a gene's transcription start site, where regulatory proteins and transcriptional machinery bind to direct transcription initiation. This process requires promoter activation, transcription initiation, elongation, and termination, resulting in a full-length mature transcript.
Transcription at unidirectional promoters produces a single gene in a single direction. In contrast, bidirectional promoters transcribe two genes with less than 1 kb between their transcription start sites. The sense and antisense genes are initiated from separate core promoters. While the regulatory functions of bidirectional promoters are not yet fully understood, studies suggest they may facilitate coregulation and decrease expression noise.
MyHC gene regulation is complex due to the presence of bidirectional intergenic promoters coordinating the expression of different MyHC isoforms. The regulatory functions of bidirectional promoters in MyHC genes may involve coregulation and noise reduction, contributing to the fine-tuning of muscle performance and phenotypic differences observed among fibre types.
Understanding Muscle Compartments: Structure and Function
You may want to see also
MyHC-2B gene has lost its function in horses
Myosin heavy chain (MyHC) is considered the best marker for fibre typing in mammalian muscles. Three MyHC isoforms (types 1, 2A, and 2X) are functionally expressed in adult equine skeletal muscles. However, a recent study has revealed that a minute amount (1%) of the fastest MyHC-2B isoform is also expressed, despite the presence of a MyHC-2B pseudogene in the equine genome.
This discovery suggests that the MyHC-2B gene has lost its function in horses during their evolutionary history. While the exact mechanism behind this loss of function is not yet fully understood, it has been attributed to the large body size of horses. However, it is important to note that the relationship between the functional presence of MyHC-2B and body size is not absolute, as this isoform is widely expressed in the skeletal muscles of other large mammals, such as pigs.
The functional absence of the MyHC-2B gene in horses has implications for our understanding of their muscle performance and fibre typing. Horses of Quarter Horse-related breeds with a specific genetic mutation in the MYH1 gene can develop myosin heavy chain myopathy (MYHM), which can present as immune-mediated myositis (IMM) or nonexertional rhabdomyolysis. This mutation causes the horse's immune system to attack its skeletal muscle cells, leading to a rapid loss of muscle size and strength.
The diagnosis of IMM and MYHM can be made through genetic testing, specifically analyzing the MYH1 gene. This allows for early detection and potentially more effective treatment options. While the MyHC-2B gene may have lost its function in horses, the presence of the MyHC-2X isoform is crucial for their muscle performance. The MyHC-2X transcript is rapidly down-regulated in horse muscle after exercise training, highlighting the dynamic nature of muscle fibre composition and function in these animals.
In summary, the MyHC-2B gene has lost its function in horses, and this loss of function is suggested to be due to their large body size. However, the relationship between body size and MyHC-2B function is not absolute. The functional absence of MyHC-2B has implications for understanding muscle-related diseases and the dynamic nature of muscle fibre composition in horses.
Chewing Muscles: What They Are and Why They Matter
You may want to see also
MyHC-emb is a regulator of mammalian myogenesis
Myosin heavy chain-embryonic (MyHC-emb) is a skeletal muscle-specific contractile protein expressed during muscle development. It is a crucial regulator of mammalian myogenesis, performing dual cell-autonomous and non-cell-autonomous functions. During mammalian muscle development, muscle progenitors called myoblasts fuse to make myofibers in two phases: embryonic and foetal. MyHC-emb is expressed in both phases.
At the cell-autonomous level, MyHC-emb regulates muscle fiber size, fiber number, and fiber type. It also plays a role in muscle differentiation, where germline loss of MyHC-emb leads to neonatal and postnatal alterations in muscle fiber characteristics and misregulation of genes involved in muscle differentiation. Deletion of Myh3, the gene encoding MyHC-emb, during embryonic myogenesis leads to depletion of the myogenic progenitor cell pool and an increase in the myoblast pool.
At the non-cell-autonomous level, MyHC-emb regulates myogenic progenitor and myoblast differentiation through the fibroblast growth factor (FGF) signaling pathway. The non-cell-autonomous effect of MyHC-emb on myogenic progenitors and myoblasts is mediated by secreted FGF signals. Supplementation with FGF in culture media rescues the myogenic differentiation defects caused by the loss of MyHC-emb function.
MyHC-emb is crucial for skeletal muscle development, and its mutations have been linked to congenital contracture syndromes such as Freeman-Sheldon and Sheldon-Hall. These mutations lead to defects in myofibre characteristics and severe scoliosis, a phenotype also observed in humans with MYH3 mutations. Thus, MyHC-emb plays a vital role in mammalian myogenesis, and its dysfunction can result in significant health issues.
Breathing and Muscle Control: A Balancing Act
You may want to see also
Frequently asked questions
MYHC stands for Myosin Heavy Chain.
Myosin Heavy Chain is a protein that is crucial for muscle development and function. It is the major protein comprising the cardiac muscle thick filament and is involved in muscle contraction.
Yes, there are different isoforms of MYHC that are expressed in various types of muscles, including skeletal muscles and cardiac muscles. In adult equine skeletal muscles, for instance, three isoforms (types 1, 2A, and 2X) are functionally expressed.
Mutations in the MYHC gene can lead to various health issues. For example, mutations in MYH3, the gene encoding MyHC-emb, can result in congenital contracture syndromes such as Freeman-Sheldon and Sheldon-Hall syndromes. Mutations in MYH6 have been associated with atrial septal defects, hypertrophic cardiomyopathy, and sick sinus syndrome.
The expression patterns of MYHC genes have been studied in relation to meat quality in cattle and pigs. The presence of certain MYHC isoforms and their association with intramuscular fat and tenderness can impact the genetic selection for meat quality traits.
